192 related articles for article (PubMed ID: 24497188)
21. Neoadjuvant chemoradiation for advanced primary vulvar cancer.
van Doorn HC; Ansink A; Verhaar-Langereis M; Stalpers L
Cochrane Database Syst Rev; 2006 Jul; (3):CD003752. PubMed ID: 16856018
[TBL] [Abstract][Full Text] [Related]
22. Robotic assisted surgery for gynaecological cancer.
Lu D; Liu Z; Shi G; Liu D; Zhou X
Cochrane Database Syst Rev; 2012 Jan; 1():CD008640. PubMed ID: 22258988
[TBL] [Abstract][Full Text] [Related]
23. Perioperative enhanced recovery programmes for gynaecological cancer patients.
Lv D; Wang X; Shi G
Cochrane Database Syst Rev; 2010 Jun; (6):CD008239. PubMed ID: 20556792
[TBL] [Abstract][Full Text] [Related]
24. Perioperative enhanced recovery programmes for gynaecological cancer patients.
Lu D; Wang X; Shi G
Cochrane Database Syst Rev; 2012 Dec; 12():CD008239. PubMed ID: 23235656
[TBL] [Abstract][Full Text] [Related]
25. Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered?
Pathiraja P; Sandhu H; Instone M; Haldar K; Kehoe S
Arch Gynecol Obstet; 2014 Mar; 289(3):657-62. PubMed ID: 24026090
[TBL] [Abstract][Full Text] [Related]
26. Perioperative enhanced recovery programmes for gynaecological cancer patients.
Lu D; Wang X; Shi G
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008239. PubMed ID: 25789452
[TBL] [Abstract][Full Text] [Related]
27. Perioperative interventions in pelvic organ prolapse surgery.
Haya N; Feiner B; Baessler K; Christmann-Schmid C; Maher C
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013105. PubMed ID: 30121957
[TBL] [Abstract][Full Text] [Related]
28. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
[TBL] [Abstract][Full Text] [Related]
29. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.
Kew F; Galaal K; Bryant A; Naik R
Cochrane Database Syst Rev; 2011 Jun; (6):CD006119. PubMed ID: 21678351
[TBL] [Abstract][Full Text] [Related]
32. Centralisation of services for gynaecological cancers - a Cochrane systematic review.
Woo YL; Kyrgiou M; Bryant A; Everett T; Dickinson HO
Gynecol Oncol; 2012 Aug; 126(2):286-90. PubMed ID: 22507534
[TBL] [Abstract][Full Text] [Related]
33. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
34. Surgical interventions for high-grade vulval intraepithelial neoplasia.
Kaushik S; Pepas L; Nordin A; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD007928. PubMed ID: 24596022
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
Galaal K; van der Heijden E; Godfrey K; Naik R; Kucukmetin A; Bryant A; Das N; Lopes AD
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006812. PubMed ID: 23450572
[TBL] [Abstract][Full Text] [Related]
36. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer.
Rogers L; Siu SS; Luesley D; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2009 Oct; (4):CD007583. PubMed ID: 19821430
[TBL] [Abstract][Full Text] [Related]
38. Pelvic exenteration. Has it a role in 1987? A six year experience.
Shepherd JH
Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
[TBL] [Abstract][Full Text] [Related]
39. [Pelvic exenterations for gynaecological cancer--a 10 year institutional review].
Pinelo S; Petiz A; Domingues C; Lopes C; Alves A; Fael R
Acta Med Port; 2006; 19(2):99-104. PubMed ID: 17187709
[TBL] [Abstract][Full Text] [Related]
40. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.
Soeda S; Furukawa S; Sato T; Ueda M; Kamo N; Endo Y; Kojima M; Nomura S; Kataoka M; Fujita S; Endo H; Takahashi T; Watanabe T; Yamada H; Fujimori K
Anticancer Res; 2019 Oct; 39(10):5631-5637. PubMed ID: 31570460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
